These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33300174)

  • 1. New clinical and molecular evidence linking mutations in ARSG to Usher syndrome type IV.
    Peter VG; Quinodoz M; Sadio S; Held S; Rodrigues M; Soares M; Sousa AB; Coutinho Santos L; Damme M; Rivolta C
    Hum Mutat; 2021 Mar; 42(3):261-271. PubMed ID: 33300174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants.
    Velde HM; Reurink J; Held S; Li CHZ; Yzer S; Oostrik J; Weeda J; Haer-Wigman L; Yntema HG; Roosing S; Pauleikhoff L; Lange C; Whelan L; Dockery A; Zhu J; Keegan DJ; Farrar GJ; Kremer H; Lanting CP; Damme M; Pennings RJE
    Hum Genet; 2022 Nov; 141(11):1723-1738. PubMed ID: 35226187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homozygous founder missense variant in arylsulfatase G abolishes its enzymatic activity causing atypical Usher syndrome in humans.
    Khateb S; Kowalewski B; Bedoni N; Damme M; Pollack N; Saada A; Obolensky A; Ben-Yosef T; Gross M; Dierks T; Banin E; Rivolta C; Sharon D
    Genet Med; 2018 Sep; 20(9):1004-1012. PubMed ID: 29300381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal imaging and genetic findings in a case of ARSG-related atypical Usher syndrome.
    Fowler NH; El-Rashedy MI; Chishti EA; Vander Kooi CW; Maldonado RS
    Ophthalmic Genet; 2021 Jun; 42(3):338-343. PubMed ID: 33629623
    [No Abstract]   [Full Text] [Related]  

  • 5. Expanding the genetic landscape of Usher syndrome type IV caused by pathogenic ARSG variants.
    Bauwens M; De Man V; Audo I; Balikova I; Zein WM; Smirnov V; Held S; Vermeer S; Loos E; Jacob J; Casteels I; Désir J; Depasse F; Van de Sompele S; Van Heetvelde M; De Bruyne M; Andrieu C; Condroyer C; Antonio A; Hufnagel R; Carvalho AL; Marques JP; Zeitz C; De Baere E; Damme M
    Clin Genet; 2025 Jan; 107(1):44-55. PubMed ID: 39199020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.
    Ebermann I; Scholl HP; Charbel Issa P; Becirovic E; Lamprecht J; Jurklies B; Millán JM; Aller E; Mitter D; Bolz H
    Hum Genet; 2007 Apr; 121(2):203-11. PubMed ID: 17171570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome.
    Igelman AD; Ku C; da Palma MM; Georgiou M; Schiff ER; Lam BL; Sankila EM; Ahn J; Pyers L; Vincent A; Ferraz Sallum JM; Zein WM; Oh JK; Maldonado RS; Ryu J; Tsang SH; Gorin MB; Webster AR; Michaelides M; Yang P; Pennesi ME
    Ophthalmic Genet; 2021 Dec; 42(6):664-673. PubMed ID: 34223797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Usher syndrome pathogenic variants identified in cases with hearing and vision loss.
    Pater JA; Green J; O'Rielly DD; Griffin A; Squires J; Burt T; Fernandez S; Fernandez B; Houston J; Zhou J; Roslin NM; Young TL
    BMC Med Genet; 2019 May; 20(1):68. PubMed ID: 31046701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
    Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
    Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel homozygous
    Abad-Morales V; Navarro R; Burés-Jelstrup A; Pomares E
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100736. PubMed ID: 32455177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between Genotype and Phenotype in 69 Chinese Patients with USH2A Mutations: A comparative study of the patients with Usher Syndrome and Nonsyndromic Retinitis Pigmentosa.
    Meng X; Liu X; Li Y; Guo T; Yang L
    Acta Ophthalmol; 2021 Jun; 99(4):e447-e460. PubMed ID: 33124170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing.
    Oishi M; Oishi A; Gotoh N; Ogino K; Higasa K; Iida K; Makiyama Y; Morooka S; Matsuda F; Yoshimura N
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7369-75. PubMed ID: 25324289
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhu T; Chen DF; Wang L; Wu S; Wei X; Li H; Jin ZB; Sui R
    Br J Ophthalmol; 2021 May; 105(5):694-703. PubMed ID: 32675063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted exon sequencing in Usher syndrome type I.
    Bujakowska KM; Consugar M; Place E; Harper S; Lena J; Taub DG; White J; Navarro-Gomez D; Weigel DiFranco C; Farkas MH; Gai X; Berson EL; Pierce EA
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8488-96. PubMed ID: 25468891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel DFNB31 mutation associated with Usher type 2 syndrome showing variable degrees of auditory loss in a consanguineous Portuguese family.
    Audo I; Bujakowska K; Mohand-Saïd S; Tronche S; Lancelot ME; Antonio A; Germain A; Lonjou C; Carpentier W; Sahel JA; Bhattacharya S; Zeitz C
    Mol Vis; 2011; 17():1598-606. PubMed ID: 21738389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome.
    Ebermann I; Phillips JB; Liebau MC; Koenekoop RK; Schermer B; Lopez I; Schäfer E; Roux AF; Dafinger C; Bernd A; Zrenner E; Claustres M; Blanco B; Nürnberg G; Nürnberg P; Ruland R; Westerfield M; Benzing T; Bolz HJ
    J Clin Invest; 2010 Jun; 120(6):1812-23. PubMed ID: 20440071
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Fu Q; Xu M; Chen X; Sheng X; Yuan Z; Liu Y; Li H; Sun Z; Li H; Yang L; Wang K; Zhang F; Li Y; Zhao C; Sui R; Chen R
    J Med Genet; 2017 Mar; 54(3):190-195. PubMed ID: 27627988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoding the consecutive lysosomal degradation of 3-O-sulfate containing heparan sulfate by Arylsulfatase G (ARSG).
    Kowalewski B; Lange H; Galle S; Dierks T; Lübke T; Damme M
    Biochem J; 2021 Sep; 478(17):3221-3237. PubMed ID: 34405855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterization of retinitis pigmentosa associated with deafness.
    Paredes ÁC; López G; Gelvez N; Tamayo ML
    Biomedica; 2022 May; 42(Sp. 1):130-143. PubMed ID: 35866736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.
    Reiners J; Nagel-Wolfrum K; Jürgens K; Märker T; Wolfrum U
    Exp Eye Res; 2006 Jul; 83(1):97-119. PubMed ID: 16545802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.